Biosimulation is used in the healthcare sector for
model-based calculation of biological systems. It is helpful in making
commercial decisions regarding the benefits of bringing a specific drug to
market. In 2022, the market for biosimulation is expected to reach US$3,435
million, increasing from US$1,476 million in 201..